60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results
August 14, 2024 11:01 ET
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharma Q2 2024 net product revenues doubled YoY to $125K, with an 18.3% sequential growth. Gross profit rose to $35K from a $124K loss.
60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split
August 06, 2024 09:26 ET
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharma (NASDAQ: SXTP) announces a 1-for-12 reverse stock split, effective August 12, 2024 to meet Nasdaq’s $1.00 minimum bid price requirement.
Primega Group Holdings Limited Announces Closing of its Initial Public Offering
July 24, 2024 12:45 ET
|
Primega Group Holdings Limited
HONG KONG, July 24, 2024 (GLOBE NEWSWIRE) -- Primega Group Holdings Limited (Nasdaq: PGHL) (the “Company”), a provider of transportation services that employs environmentally friendly practices with...
Primega Group Holdings Limited Announces Pricing of its Initial Public Offering
July 22, 2024 14:04 ET
|
Primega Group Holdings Limited
HONG KONG, July 22, 2024 (GLOBE NEWSWIRE) -- Primega Group Holdings Limited (Nasdaq: PGHL) (the “Company”), a provider of transportation services that employs environmentally friendly practices with...
Vision Sensing Acquisition Corp. Announces Successful Application to Nasdaq Stock Exchange for VSAC to Migrate to the Nasdaq Capital Market
July 18, 2024 18:00 ET
|
Vision Sensing Acquisition Corp.
New York, NY, July 18, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that it has...
RDE, Inc. Submits Application for Uplisting to the Nasdaq Capital Market
January 23, 2024 08:30 ET
|
RDE, Inc.
Schaumburg, IL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- RDE, Inc. (OTCQB: RSTN) (“RDE” or “Company”), the owner and operator of leading digital platforms, Restaurant.com and CardCash.com, with a focus on...
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
January 16, 2024 18:15 ET
|
EUDA Health Holdings Limited
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Nasdaq on January 9, 2024 indicating...
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements
September 22, 2023 08:00 ET
|
EUDA Health Holdings Limited
Singapore, Sept. 22, 2023 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Listing Qualifications Department of The...
BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market
July 24, 2023 11:30 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”) (Nasdaq: BGLC), an emerging company in the business of selling chemical raw materials...
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
July 20, 2023 13:29 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, July 20, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”), an emerging company in the business of selling chemical raw materials in the...